Anti‐Müllerian hormone exhibits a great variation in infertile women with different ovarian reserve patterns

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Australian and New Zealand journal of obstetrics and gynaecology

• Publication date

  2017-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/ajo.12625PMID 28419409
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multicenter analytical performance evaluation of a fully automated anti-Müllerian hormone assay and reference interval determination.

  2016cited by this paper
• Biological variability in serum anti-Müllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women.

  2014cited by this paper
• Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach.

  2013cited by this paper
• How Much Does AMH Really Vary in Normal Women?

  2013cited by this paper
• Within-laboratory and between-laboratory variability in the measurement of anti-müllerian hormone determined within an external quality assurance scheme.

  2013cited by this paper
• Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis.

  2013cited by this paper
• Variation in antimüllerian hormone concentration during the menstrual cycle may change the clinical classification of the ovarian response.

  2013cited by this paper
• Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability.

  2012cited by this paper
• Anti-Müllerian Hormone Level in Older Women: Detection of Granulosa Cell Tumor Recurrence

  2012cited by this paper
• Intra-cycle fluctuations of anti-Müllerian hormone in normal women with a regular cycle: a re-analysis.

  2012cited by this paper
• Anti-Mullerian hormone--is it a crystal ball for predicting ovarian ageing?

  2011cited by this paper
• Anti-Müllerian hormone and inhibin B variability during normal menstrual cycles.

  2010cited by this paper
• Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).

  2010cited by this paper
• Development of a second generation anti-Müllerian hormone (AMH) ELISA.

  2010cited by this paper
• The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count.

  2009cited by this paper
• Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.

  2009cited by this paper
• Clinical uses of anti-Müllerian hormone assays: pitfalls and promises.

  2009cited by this paper
• Statistically significant changes of antimüllerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women.

  2008cited by this paper
• Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology.

  2007cited by this paper
• Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy.

  2007cited by this paper
• Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation.

  2006cited by this paper
• Men at risk: occupation and male infertility.

  2004cited by this paper
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

  2004cited by this paper
• Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

  2004cited by this paper
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

  2004cited by this paper
• ACOG Practice Bulletin No. 36: Obstetric Analgesia and Anesthesia

  2002cited by this paper
• Serum müllerian-inhibiting substance levels during normal menstrual cycles.

  2000cited by this paper
• Clinical gynecologic endocrinology and infertility

  1991cited by this paper
• American College of Obstetricians and Gynecologists

  1979cited by this paper

• Papel de la hormona "antimülleriana" en la reproducción

  2024cites this paper
• Analysis of two layered peristaltic-ciliary transport of Jeffrey fluid and in vitro preimplantation embryo development

  2024cites this paper
• Variability of serum anti-Mullerian hormone level and antral follicle count in an unstimulated menstrual cycle

  2023cites this paper
• The Stability of the Anti-Müllerian Hormone in Serum and Plasma Samples under Various Preanalytical Conditions

  2023cites this paper
• Searching for female reproductive aging and longevity biomarkers

  2021cites this paper
• Nomogram of age-specific anti-Müllerian hormone levels in healthy Egyptian females

  2021cites this paper
• KLUCZOWA ROLA KISSPEPTYN W REGULACJI PROCESÓW ROZRODCZYCH SAMIC

  2019cites this paper
• Comparison of Automated Anti-Müllerian Hormone Assays and Antral Follicle Count in Predicting Ovarian Response During Ovarian Stimulation

  2019cites this paper
• Anti‐Müllerian hormone variability and its implications for the number of oocytes retrieved following individualized dosing with follitropin delta

  2019cites this paper
• Anti-müllerian Hormone During Natural Cycle Presents Significant Intra and Intercycle Variations When Measured With Fully Automated Assay

  2018cites this paper
• Anti-müllerian hormone variability during ovarian stimulation for IVF : A novel approach to predict fertility treatment outcomes

  2018cites this paper